Clinical trial

Access to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP)

NCT03459157

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-11-20

PhaseNA

Study timeline

Study start (actual)2017-11-20Date precision: day

Registry last updated2026-04-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV/AIDSunresolved

Interventions

HIV prevention package including PrEPDRUG

Sponsors & collaborators

ANRS, Emerging Infectious Diseaseslead sponsor

Expertise Francecollaborator

Université Montpelliercollaborator

SESSTIM (IRD, Inserm, Université Aix-Marseille)collaborator

Coalition Internationale Sidacollaborator

Institut de Médecine Tropicale, Anvers, Belgiquecollaborator

ARCAD-SIDA MALIcollaborator

Association African Solidaritécollaborator

Centre de Recherche Internationale pour la Santé, Université de Ouagadougoucollaborator

Espace Confiance, Côte d'Ivoirecollaborator

Espoir Vie-Togo - ONGcollaborator

Laboratoire BIOLIM, Université de Lomécollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03459157 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.